An institutional view of medicinal herbs.
The Medicinal Herbs project focuses on open-field organic cultivation of high-demand Ayurvedic botanicals including Ashwagandha, Tulsi, Brahmi, and Shatavari across climatically optimized growing regions. With a 180-day cultivation cycle, this project capitalizes on India's burgeoning herbal wellness market, projected to reach ₹1.5 trillion by 2028. The unit economics are compelling: per-acre cultivation costs average ₹85,000-₹1,20,000 with gross revenues reaching ₹2,80,000-₹3,50,000 depending on herb selection and yield optimization, delivering an expected IRR of 24%.
Strong offtake agreements with industry leaders—Himalaya Drug Company, Patanjali Ayurved, and Dabur India—eliminate price volatility and ensure guaranteed procurement at pre-negotiated rates. These partnerships also provide access to certified organic seed varieties and agronomic protocols compliant with Good Agricultural Practices (GAP) and organic certification standards. The contract-farming model significantly de-risks market exposure while ensuring premium pricing for certified organic produce.
AgriBrainiers brings differentiated value through its network of agronomist partners specializing in medicinal crop cultivation, real-time crop health monitoring systems, and direct relationships with phytochemical testing laboratories ensuring alkaloid and active compound specifications. Key operational risks include weather aberrations affecting active ingredient concentration, pest pressures in organic systems, and certification timeline delays. However, our diversified herb portfolio, insurance coverage, and rigorous quality assurance protocols substantially mitigate these vulnerabilities, positioning this as an attractive agriculture-linked investment opportunity.
Common questions.
Generated for this project from AgriBrainiers' underwriting notes.
Ready to plant capital
in medicinal herbs?
Choose Debt for fixed 18% or Equity for 30% tax-free profit share. Quarterly payouts either way.